Interruption of antiretroviral therapy to augment immune control of chronic HIV-1 infection: risk without reward

Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13377-8. doi: 10.1073/pnas.212518999. Epub 2002 Oct 7.
No abstract available

Publication types

  • Comment
  • Review

MeSH terms

  • Anti-HIV Agents / administration & dosage*
  • Antiretroviral Therapy, Highly Active
  • CD4 Lymphocyte Count
  • CD8-Positive T-Lymphocytes / drug effects
  • CD8-Positive T-Lymphocytes / immunology
  • Drug Administration Schedule
  • HIV Infections / drug therapy*
  • HIV Infections / immunology*
  • HIV Infections / virology
  • HIV-1
  • Humans
  • RNA, Viral / blood
  • Risk Factors

Substances

  • Anti-HIV Agents
  • RNA, Viral